Aim 2

Evaluate and validate lung imaging biomarkers for early detection, first based on NLST low-dose CT (LDCT) cohorts and then expanding with a newly-established cohort of higher resolution LDCT. (Bob Gillies, PhD, Matt Schabath, PhD., Co-Leads).

Lung Cancer